We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TYRA icon
126
Tyra Biosciences
TYRA
$1.71B
$1.71B $28.65 15.2%
NVAX icon
127
Novavax
NVAX
$1.69B
$1.69B $10.22 1.16%
FTRE icon
128
Fortrea Holdings
FTRE
$1.68B
$1.68B $17.70 4.94%
ANAB icon
129
AnaptysBio
ANAB
$1.68B
$1.68B $56.80 1.15%
AVLN
130
Avalyn Pharma
AVLN
$1.66B
$1.66B $37.39 5.5%
AAPG
131
Ascentage Pharma
AAPG
$1.64B
$1.64B $17.61 1.44%
SLBT
132
SL Science Holding Ltd
SLBT
$1.61B
$1.61B $2.88 8.57%
LBRX
133
LB Pharmaceuticals
LBRX
$1.59B
$1.59B $49.34 3.83%
INVA icon
134
Innoviva
INVA
$1.54B
$1.54B $21.33 0.09%
BCAX
135
Bicara Therapeutics
BCAX
$1.53B
$1.53B $23.17 0.73%
AVBP icon
136
ArriVent BioPharma
AVBP
$1.53B
$1.53B $30.95 0.26%
ABSI icon
137
Absci
ABSI
$1.51B
$1.51B $8.82 0.23%
RARE icon
138
Ultragenyx Pharmaceutical
RARE
$1.51B
$1.51B $15.30 3.03%
AKTS
139
Aktis Oncology
AKTS
$1.5B
$1.5B $27.05 1.5%
VOR icon
140
Vor Biopharma
VOR
$1.48B
$1.48B $25.05 3.34%
LTGO
141
Latigo Biotherapeutics
LTGO
$1.46B
$1.46B $23.04 2.49%
MAZE
142
Maze Therapeutics
MAZE
$1.46B
$1.46B $26.21 1.31%
IMTX icon
143
Immatics
IMTX
$1.46B
$1.46B $9.56 1.06%
TRAX
144
First Tracks Biotherapeutics
TRAX
$1.45B
$1.45B $40.46 4.82%
ALMS
145
Alumis Inc
ALMS
$1.44B
$1.44B $11.10 2.29%
CGEM icon
146
Cullinan Oncology
CGEM
$1.42B
$1.42B $22.09 0.32%
REPL icon
147
Replimune Group
REPL
$1.42B
$1.42B $15.04 1.64%
ANRO icon
148
Alto Neuroscience
ANRO
$1.4B
$1.4B $35.55 2.34%
DRTS icon
149
Alpha Tau Medical
DRTS
$1.39B
$1.39B $15.03 2.8%
ODTX
150
Odyssey Therapeutics
ODTX
$1.38B
$1.38B $28.76 8.94%
4 5
6
7 8

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 568 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.35T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $138B, Regeneron Pharmaceuticals (REGN) at $85.2B and argenx (ARGX) at $64.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 243 funds opened new positions, taking total fund holders up 177 (34%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.